Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Bausch Health Companies Inc.    BHC   CA0717341071

BAUSCH HEALTH COMPANIES INC.

(BHC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Bausch: 1Q Earnings Snapshot

share with twitter share with LinkedIn share with facebook
share via e-mail
05/07/2020 | 07:40am EDT

LAVAL, Quebec (AP) _ Bausch Health Companies Inc. (BHC) on Thursday reported a loss of $152 million in its first quarter.

The Laval, Quebec-based company said it had a loss of 43 cents per share. Earnings, adjusted for one-time gains and costs, were 89 cents per share.

The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 90 cents per share.

The drugmaker posted revenue of $2.01 billion in the period, also missing Street forecasts. Six analysts surveyed by Zacks expected $2.05 billion.

Bausch expects full-year revenue in the range of $7.8 billion to $8.2 billion.

Bausch shares have decreased 43% since the beginning of the year. The stock has declined 33% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BHC at https://www.zacks.com/ap/BHC

Automated Insights, source Associated Press News

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on BAUSCH HEALTH COMPANIES IN
07/08TSX edges higher as gold prices rise, virus concerns cap gains
RE
06/24BAUSCH HEALTH : Ortho dermatologics announces arazlo lotion, 0.045%, now availab..
AQ
06/24BAUSCH HEALTH COMPANIES INC : . - Ortho Dermatologics Launches ARAZLO Lotion, 0...
AQ
06/23BAUSCH HEALTH : Ortho Dermatologics Launches ARAZLO™ (tazarotene) Lotion, ..
AQ
06/18BAUSCH HEALTH : + LOMB ULTRA Silicone Hydrogel Contact Lenses Receive Approval i..
AQ
06/11BAUSCH HEALTH : Health Canada Issues Notice of Compliance for Bausch Health's DU..
AQ
06/09EXCLUSIVE : Chanel, Revlon, L'Oreal pivoting away from talc in some products
RE
06/09EXCLUSIVE : Chanel, Revlon, L'Oreal pivoting away from talc in some products
RE
06/05BAUSCH HEALTH : FDA Provides 510(k) Clearance For BAUSCH + LOMB INFUSE Daily Dis..
AQ
05/28BAUSCH HEALTH : + Lomb Announces The European Launch Of LuxSmart And LuxGood Pre..
AQ
More news
Financials (USD)
Sales 2020 8 039 M - -
Net income 2020 -411 M - -
Net Debt 2020 22 174 M - -
P/E ratio 2020 -16,3x
Yield 2020 -
Capitalization 6 616 M 6 616 M -
EV / Sales 2019
EV / Sales 2020 3,58x
Nbr of Employees 21 700
Free-Float 99,4%
Chart BAUSCH HEALTH COMPANIES INC.
Duration : Period :
Bausch Health Companies Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAUSCH HEALTH COMPANIES IN
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 27,30 $
Last Close Price 18,65 $
Spread / Highest target 243%
Spread / Average Target 46,4%
Spread / Lowest Target -24,9%
EPS Revisions
Managers
NameTitle
Joseph C. Papa Chairman & Chief Executive Officer
Paul S. Herendeen Chief Financial Officer & Executive Vice President
Tage Ramakrishna Chief Medical Officer, President-R&D
Robert N. Power Independent Director
David Robert Hale Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BAUSCH HEALTH COMPANIES INC.-37.67%6 172
JOHNSON & JOHNSON1.41%389 709
ROCHE HOLDING AG5.59%300 114
MERCK & CO., INC.-13.96%197 511
PFIZER, INC.-10.08%195 697
NOVARTIS AG-11.32%191 193